For malignancy detection, SMAD4/TP53 mutation detected in pancreatic fluid can distinguish PDAC from IPMN cases, with a 32.4% sensitivity and 100% specificity [54]. The gene discussed is SMAD4; the disease is pancreatic intraductal papillary-mucinous neoplasm.